# Safety and Effectiveness of Giving L-743,872 to Patients With Thrush That Has Not Been Cured With Fluconazole

> **NCT00005920** · PHASE2 · TERMINATED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 70 (—)

## Conditions studied

- Candidiasis, Oral
- HIV Infections

## Interventions

- **DRUG:** L-743,872

## Key facts

- **NCT ID:** NCT00005920
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 70 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005920

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005920, "Safety and Effectiveness of Giving L-743,872 to Patients With Thrush That Has Not Been Cured With Fluconazole". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00005920. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*